Antimicrobial prophylaxis in women with recurrent urinary tract infections
- PMID: 22055655
- DOI: 10.1016/j.ijantimicag.2011.09.005
Antimicrobial prophylaxis in women with recurrent urinary tract infections
Abstract
Recurrent urinary tract infections (UTIs) in women are common, result in considerable morbidity and expense, and can be a management problem for clinicians. Behavioural changes can be useful antimicrobial-sparing measures in the prevention of recurrent UTIs, but antimicrobial prophylaxis may be necessary in those who continue to have recurrences. Continuous prophylaxis, post-coital prophylaxis and intermittent self-treatment with antimicrobials have all been demonstrated to be effective in the prevention of recurrent uncomplicated UTIs. The decision as to which approach to use depends upon the frequency and pattern of recurrences and willingness of the patient to commit to a specific regimen. The risk of adverse events, including antimicrobial resistance, patient's lifestyle and compliance and plans for a pregnancy also need to be considered. The choice of antimicrobial should be based upon the susceptibility pattern of the organisms causing the patient's previous UTIs and history of drug allergies.
Copyright © 2011 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Similar articles
-
Treatment of urinary tract infections.Aust Fam Physician. 1995 Dec;24(12):2205-11. Aust Fam Physician. 1995. PMID: 8588757 Review.
-
The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience.Int J Antimicrob Agents. 2007 Jul;30(1):40-3. doi: 10.1016/j.ijantimicag.2007.02.017. Epub 2007 Apr 24. Int J Antimicrob Agents. 2007. PMID: 17459663
-
Prevention of recurrent urinary tract infections in women: antimicrobial and nonantimicrobial strategies.Infect Dis Clin North Am. 2014 Mar;28(1):135-47. doi: 10.1016/j.idc.2013.10.001. Epub 2013 Dec 7. Infect Dis Clin North Am. 2014. PMID: 24484580 Review.
-
Management of urinary tract infections in the era of increasing antimicrobial resistance.Med Clin North Am. 2013 Jul;97(4):737-57, xii. doi: 10.1016/j.mcna.2013.03.006. Epub 2013 Apr 29. Med Clin North Am. 2013. PMID: 23809723 Review.
-
Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women.BJU Int. 2014 Jan;113(1):9-10. doi: 10.1111/bju.12492. BJU Int. 2014. PMID: 24215164 Clinical Trial. No abstract available.
Cited by
-
Urinary excretion of ciprofloxacin after administration of extended release tablets in healthy volunteers. Swellable drug-polyelectrolyte matrix versus bilayer tablets.Drug Deliv Transl Res. 2018 Feb;8(1):123-131. doi: 10.1007/s13346-017-0442-z. Drug Deliv Transl Res. 2018. PMID: 29159694 Clinical Trial.
-
Unrecognized Interstitial Lung Disease as a Result of Chronic Nitrofurantoin Use.Drug Saf Case Rep. 2016 Dec;3(1):13. doi: 10.1007/s40800-016-0037-5. Drug Saf Case Rep. 2016. PMID: 27778245 Free PMC article.
-
Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial.Int Urogynecol J. 2014 Sep;25(9):1173-8. doi: 10.1007/s00192-013-2318-1. Epub 2014 Feb 20. Int Urogynecol J. 2014. PMID: 24554302 Clinical Trial.
-
Management of recurrent urinary tract infections in healthy adult women.Rev Urol. 2013;15(2):41-8. Rev Urol. 2013. PMID: 24082842 Free PMC article.
-
The use of chemotherapeutic agents as prophylaxis for recurrent urinary tract infection in healthy nonpregnant women: A network meta-analysis.Indian J Urol. 2019 Apr-Jun;35(2):147-155. doi: 10.4103/iju.IJU_378_18. Indian J Urol. 2019. PMID: 31000921 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical